Study of Baricitinib and Adalimumab for Children Aged 2 to 17 with Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

Registered drugNo placebo

Study of Baricitinib and Adalimumab for Children Aged 2 to 17 with Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Adalimumab
Sponsor:Eli Lilly & Co.

Contact Research Centre

Other cities in Italy

The busiest research cities in the country

All 230 cities in Italy

Clinical research in Arezzo

What the registry says about research in the country

01 Urological Oncology

Extensive research focusing on bladder cancer treatments, including innovative therapies combining immunotherapy with established treatments. Studies evaluate new approaches for both muscle-invasive and non-muscle invasive disease.

Bladder Cancer Immunotherapy
Urothelial Carcinoma Treatment
BCG Combination Therapies

Multiple trials exploring targeted treatments for patients with various stages of disease progression.

02 Prostate Cancer Research

Advanced studies examining new therapeutic approaches for metastatic prostate cancer, including novel drug combinations and targeted therapies for specific genetic mutations.

Castration-resistant Disease
Targeted Molecular Therapies
Hormone-based Treatments

Investigating innovative treatment sequences and combinations to improve patient outcomes.

03 Kidney Cancer Innovations

Cutting-edge research in renal cell carcinoma treatment, exploring immunotherapy combinations and targeted approaches for both early-stage and metastatic disease.

Immunotherapy Combinations
Targeted Molecular Agents
Advanced Disease Management

Focus on improving survival rates through novel therapeutic strategies.

Back to Italy All countries

Clinical trials in Arezzo – page 64

1 011 trials in Arezzo

Prostate cancer recurrent

Study on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer

Squamous cell carcinoma of head and neck

Study on Xevinapant and Radiotherapy for High-Risk Head and Neck Cancer Patients Unable to Take High-Dose Cisplatin

Hepatocellular carcinoma

Study of Nivolumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation

Bladder cancer

Study on the Effectiveness and Safety of Durvalumab with Gemcitabine and Cisplatin for Patients with Muscle-Invasive Bladder Cancer

Systemic lupus erythematosus

Study on MK-6194 for Adults with Systemic Lupus Erythematosus

Gastric cancer

Study of ALX148 with Trastuzumab, Ramucirumab, and Paclitaxel for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

Plasma cell myeloma

Study of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy

Atypical haemolytic uraemic syndrome

Study on the Effects and Safety of Crovalimab for Adults and Adolescents with Atypical Hemolytic Uremic Syndrome (aHUS)

Idiopathic pulmonary fibrosis

Study on the Effects of Bexotegrast for Patients with Idiopathic Pulmonary Fibrosis

Hypertrophic cardiomyopathy

Study on Aficamten for Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

Colitis ulcerative

Study on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Ulcerative Colitis

Uveitis

Study of Baricitinib and Adalimumab for Children Aged 2 to 17 with Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

Filter the trials

Other cities in Italy

Clinical research in Arezzo

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Clinical trials in Arezzo – page 64

1 011 trials in Arezzo

Other cities in Italy

Related

Clinical research in Arezzo

Prefer not to search on your own, or looking for clinical trials for a rare disease?